949 related articles for article (PubMed ID: 11990081)
1. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
2. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
Daniel WA; Syrek M; Ryłko Z; Kot M
Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
[TBL] [Abstract][Full Text] [Related]
3. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
[TBL] [Abstract][Full Text] [Related]
4. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Ball SE; Ahern D; Scatina J; Kao J
Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
[TBL] [Abstract][Full Text] [Related]
8. Caffeine metabolism during prolonged treatment of rats with antidepressant drugs.
Kot M; Wójcikowski J; Daniel WA
Pharmacol Rep; 2007; 59(6):727-33. PubMed ID: 18195463
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
Daniel WA; Syrek M; Haduch A
Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
11. Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants.
Syrek M; Wójcikowski J; Daniel WA
Pol J Pharmacol; 1997; 49(6):453-62. PubMed ID: 9566049
[TBL] [Abstract][Full Text] [Related]
12. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
Jones DR; Gorski JC; Hamman MA; Mayhew BS; Rider S; Hall SD
J Pharmacol Exp Ther; 1999 Sep; 290(3):1116-25. PubMed ID: 10454485
[TBL] [Abstract][Full Text] [Related]
13. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
Koyama E; Chiba K; Tani M; Ishizaki T
J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
16. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats.
Zhang XJ; Thomas PE
Drug Metab Dispos; 1996 Jan; 24(1):23-7. PubMed ID: 8825186
[TBL] [Abstract][Full Text] [Related]
18. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
20. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.
Daniel WA; Haduch A; Syrek M; Boksa J
Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]